Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
equity investment
Research
Lower drug prices won't hurt biotech innovation, 2 studies show
Analyses of R&D spending and equity investment in biotech predict that the industry can weather a drop in revenue due to lower drug prices.
Darren Incorvaia
Jul 31, 2024 2:30pm
Mainstay Medical merits $125M for back pain neuromod implant
Feb 28, 2024 12:07pm
Pfizer pours $25M investment into Caribou CAR-Ts
Jul 6, 2023 8:00am
Henko Partners looks to form European CRO with latest investment
May 10, 2023 4:00pm
Pfizer boosts ORIC shares with multiple myeloma collaboration
Dec 22, 2022 11:20am
SFW invests in Sannova Analytical citing market opportunities
Aug 10, 2022 5:30pm
